Toll-like receptor 4 (TLR4) is a transmembrane receptor, which upon activation by lipopolysaccharide (LPS) from Gram-negative bacteria, plays an important role in the induction of the innate immune response. Our lab has previously demonstrated that activation of TLR4 in skeletal muscle results in the preferential oxidation of glucose for ATP production over that of fatty acids. Currently, the exact mechanism(s) for TLR4-induced modulation of metabolism are not known. The purpose of this project was to test the hypothesis that activation of TLR4 pathway causes increased ROS production, which contributes to deceased fatty acid oxidation and altered mitochondrial respiration in skeletal muscle. To this end, skeletal muscle cells were studied following acute and chronic treatments with LPS, and a mouse model with muscle-specific over expression of TLR4 (mTLR4) was studied under chow fed conditions and following 16 weeks of high fat feeding. Acute LPS treatment of C2C12 cells resulted in mitochondrial uncoupling as evidenced by higher levels of state IV respiration, reduced maximally simulated respiration, and a robust induction of uncoupling protein 3. These observations occurred in conjunction with increased pyruvate dehydrogenase activity. The LPS-induced changes in substrate preferences and maximally-stimulated mitochondrial respiration were prevented in the presence of the antioxidants, N-acetyl-L-cyteine (NAC) and catalase. Using isolated flexor digitorum brevis (FDB) muscle fibers from C57BL/6J mice, we showed that LPS treatment results in significant increases in ROS production that are evident at 15 min and still increasing at 45 min following the addition of LPS to incubation media. Hyperpolarization of mitochondrial membrane potential was also evident at 15 min post LPS treatment in FDB fibers. Fatty acid oxidation measured in skeletal muscle whole homogenates from the mTLR4 mice was significantly reduced compared to wild-type littermates on a standard chow diet. Following a 16 week high fat diet, the mTLR4, compared to wild-type mice, gained more weight and fat mass, were glucose intolerant, and displayed elevated production of mitochondrial-derived reactive oxygen species (ROS) from complex III. In conclusion, these data show that TLR4 activation elicits a change in mitochondrial substrate preference in that acetyl-CoA derived from pyruvate oxidation is the preferred substrate for the TCA cycle over that derived from β-oxidation of fatty acids. These data also lend strong support to the idea that the TLR4-mediated change in substrate preference is dependent on the production of ROS. / Ph. D.

Lipopolysaccharide (LPS), a Gram-negative endotoxin, has been well-established as the trigger for the effects of sepsis and septic shock through its binding with the innate immune receptor, Toll-like receptor 4 (TLR4). High doses of LPS signal through TLR4 to produce a massive release of pro-inflammatory cytokines including IL-6, TNFα, and other. Additionally, several recent publications have demonstrated severe metabolic alterations after LPS challenge, suppressing lipid oxidation and concurrently up-regulating glucose oxidation. Unfortunately, this switch in metabolism is inefficient for the great energy demands of the host during a systemic microbial infection which can result in vital organ failure. Meanwhile, a novel concept in several chronic disease pathologies also implicates LPS, although at very low doses. The presence of subclinically elevated circulating endotoxin levels has been termed metabolic endotoxemia and is beginning to be investigated in disease pathologies including insulin resistance and type II diabetes, atherosclerosis, cancer metastasis and Parkinson's disease. These disease phenotypes all possess a component of chronic inflammation whose source has not largely been understood, but examining the effects of very low doses of LPS may provide vital information in understanding their etiologies. However, most information on LPS signaling has been obtained using high doses of LPS (10-200ng/ml) while little to no studies have been published regarding the effects of very low doses of LPS (1pg-100pg/ml) on inflammatory and metabolic alterations. Thus, we use in vivo and in vitro models to determine that both IRAK1 and JNK are critical points of crosstalk downstream of TLR4 for the metabolic and inflammatory alterations associated with metabolic endotoxemia. Additionally, we observed significant down-regulation of nuclear receptors responsible for fatty acid metabolism, including PGC1α, PPARα, and PPARγ after very low dose LPS challenge. Further, we observe phenotypic changes in fatty acid oxidation and glucose oxidation, as well as subsequent changes in cytosolic acetyl-CoA levels and acetylation of pro-inflammatory transcription factor ATF2. Overall our studies point to several mechanisms of cross-talk between metabolism and inflammation and offer significant support to the concept of metabolic endotoxemia in the development of chronic disease. / Ph. D.

Innate leukocytes manifest dynamic and distinct inflammatory responses upon challenges with rising dosages of pathogen associated molecular pattern molecules (PAMPs) such as lipopolysaccharide (LPS). To differentiate signal strengths, innate leukocytes may utilize distinct intra-cellular signaling circuitries modulated by adaptor molecules. Toll-interacting protein (Tollip) is one of the critical adaptor molecules in Toll-like receptor 4 (TLR4) signaling and potentially playing key roles in modulating the dynamic adaptation of innate leukocytes to varying dosages of external stimulants. While Tollip may serve as a negative regulator of NFkB signaling pathway in cells challenged with higher dosages of LPS, it acts as a positive regulator for low-grade chronic inflammation in leukocytes programmed by subclinical low-dosages of LPS. We aim to show recent progress in our understanding of complex innate leukocyte dynamics and its relevance in the pathogenesis of resolving versus non-resolving chronic inflammatory diseases. / Ph. D.

Toll like receptor-4 (TLR4) is a transmembrane inflammatory receptor expressed ubiquitously on the cell surface of immune cells as well as skeletal muscle and other metabolic tissues. A compelling body of evidence shows that muscle TLR4 and the downstream cytokine signaling modulate skeletal muscle metabolism. Intriguingly, skeletal muscle has been demonstrated to gain favorable inflammatory cytokine-mediated metabolic adaptations in the context of exercise training. This paradigm suggests a role for muscle TLR4 inflammatory signaling in the regulation of exercise metabolism. As such, the question arises as to whether exercise stress response follows similar inflammatory physiological pathways to those activated by other physical and pathogenic stimuli or not. Therefore, the objective of the present study was to investigate the role of muscle TLR4 signaling in modulating skeletal muscle cytokine, also known as myokine, response and metabolic adaptations to exercise. To this end, using Cre-mediated recombination, we developed a novel muscle-specific TLR4 knockout (mTLR4-/-) mouse model on C57BL/6JJ background. The differential inflammatory and metabolic responses between mTLR4-/- mice and wild type (WT) littermates were examined following exposure to either exercise or muscle stimulus. Accordingly, different exercise and muscle contraction modalities were pursued, focusing on voluntary wheel running, forced treadmill training, and in vivo electrical muscle stimulation. Overall, this study introduces a novel muscle-specific TLR4 knockout mouse model and discloses a crucial role for mTLR4 in basal systemic cytokine homeostasis. Furthermore, our findings identify mTLR4 as a major immunomodulatory effector of exercise-induced metabolic adaptations and suggest a link between mTLR4 and physiological determinants of maximal aerobic performance. / Ph. D.

published_or_final_version / Transport Policy and Planning / Master / Master of Arts

Les récepteurs Toll-like (TLRs) détectent des structures conservées exprimées par différentes classes de microorganismes, jouant ainsi un rôle majeur dans la réponse immunitaire. Les TLRs localisés dans les endosomes (TLR3, 7, 8 et 9) reconnaissent principalement des acides nucléiques dérivés de microbes. Cependant, ils peuvent également être responsables de la reconnaissance d’acides nucléiques endogènes et contribuer au développement d’auto immunité. A la différence du TLR8humain, le TLR8 murin n’induit pas de réponse à l’ARN simple brin et a ainsi été considéré comme non fonctionnel. Le but de cette étude est d’étudier le rôle du TLR8 murin dans l’immunité. Nous avons montré que les cellules dendritiques déficientes en TLR8 surexpriment le TLR7 et présentent une réponse accrue à une stimulation de TLR7. Chez la souris, la déficience en TLR8 entraine une augmentation des taux d’anticorps circulant (IgM, IgG, IgG2a), des autoanticorps, et au niveau rénal la présence de dépôts de complexes immuns. A l’inverse des souris TLR8-/-, les souris TLR7/8-/- sont protégées de tout symptôme. Nos résultats indiquent donc que chez la souris le TLR8 joue un rôle primordial dans la modulation de l’expression de TLR7, et cette régulation est cruciale dans le contrôle du développement d’autoimmunité spontanée. / Toll-like receptors (TLRs) detect conserved molecular products of microorganisms and play anessential role in the induction of immune responses. Endosomal TLRs (TLR3, 7, 8 and 9) sensenucleic acids derived from microbes. However they can also recognize self nucleic acids and thus beinvolved in the development of autoimmunity. Unlike human TLR8, murin TLR8 does not respond tosingle-stranded RNA suggesting that it could be not functional. In the current study, we investigatedthe role of murine TLR8 signaling in immunity. We found that TLR8-/- dendritic cells overexpressTLR7 and are hyperesponsive to various TLR7 ligands. In mice, TLR8 deficiency leads to increasedlevels of IgM, IgG, IgG2a circulating antibodies, autoantibodies and in the kidney to higher depositionof immunocomplexes while double TLR7/8-/- mice are protected from autoimmune features. Thesedata provide evidence for a pivotal role of murine TLR8 in the regulation of murine TLR7 expressionand this control is critical for the prevention of spontaneous autoimmunity development.

Diversos estudos tem demonstrado que as células-tronco mesenquimais (CTM) são imbuídas de uma forte atividade imunossupressora in vitro, no entanto, os resultados de imunoterapias utilizando CTM têm sido variáveis até o momento. Nossa hipótese para tal variação são interações que devem ocorrer entre as CTM e fragmentos de patógenos circulantes nos pacientes, resultando na modulação da atividade imunossupressora. Para avaliar a ocorrência deste fenômeno em CTM de medula óssea, inicialmente foi avaliado a presença de diversos TLR através da marcação com anticorpos e posterior quantificação por citometria de fluxo, sendo observada a presença dos TLR2, TLR3, TLR4 e TLR9. No intuito de avaliar alterações no potencial imunossupressor, linfócitos T ativados e marcados a nível intracelular foram co-cultivados com CTM estimuladas com LPS, POLY IC e oligonucleotídeos com motivos CpG: DSP30, CpG-A e CpG-B, sendo sua proliferação quantificada por citometria de fluxo. Como resultados, foi observado que a estimulação com LPS e DSP30 levaram a perda e acentuação da capacidade supressora, respectivamente, enquanto o estímulo simultâneo com LPS e DSP30 resultou em sua manutenção. Tais modulações na imunossupressão foram corroboradas ao serem avaliadas modulações na expressão gênica, tendo em vista que o estímulo por LPS e DSP30 induziram no aumento da expressão de IL1 e TGF, respectivamente. Em seguida, foi avaliado o efeito das mesmas condições experimentais na indução a proliferação das CTM, ao ser mensurada alterações na quantidade de células em um equipamento de High content Screening (HCS). Como resultados, foi possível observar que somente o tratamento com DSP30 foi capaz de aumentar significativamente a quantidade de células, fenômeno corroborado ao ser mensurada a síntese de DNA, através da utilização de um produto comercial, seguido de análise por citometria de fluxo. No intuito de avaliar possíveis modulações na via NF-B, CTM estimuladas com LPS ou DSP30 foram sujeitas ao ensaio de imunoprecipitação de cromatina, utilizando anticorpos específicos a subunidades de RelA e RelB, sendo o DNA imunoprecipitado sujeito a PCR quantitativo com primers específicos para a regiões promotoras do gene VCAM-1. Como resultados, foi observado que o estímulo com LPS aumentou a atividade do RelA, enquanto não foram observados efeitos após o estímulo com DSP30. No entanto, o estímulo simultâneo com ambos os ligantes levou ao aumento de atividade de RelA e RelB. Ao serem avaliadas estas condições em um ensaio de imunofluorescência analisado em HCS, foi possível observar maiores níveis da proteína RelB no citoplasma das células tratadas com DSP30, sugerindo um aumento da sua formação. Apesar dos mecanismos moleculares subjacentes aos resultados observados ainda necessitarem de maior elucidação, nosso trabalho indica que a estimulação das CTM com DSP30 pode trazer benefícios no sentido de potencializar a imunossupressão e proliferação celular, além de impedir a perda da imunossupressão, decorrente da interação com LPS. Tais resultados poderão servir como diretrizes para o aprimoramento de imunoterapias utilizando CTM de medula óssea, principalmente em casos de pacientes com infecções por patógenos. / Several studies have shown that mesenchymal stem cells (MSCs ) are imbued with a strong immunosuppressive activity in vitro , however , the results of immunotherapies using CTM has been mixed so far. Our hypothesis for this variation are interactions that must occur between the CTM and fragments of circulating pathogens in patients , resulting in the modulation of the immunosuppressive activity. To evaluate the occurrence of this phenomenon in bone marrow MSCs was initially evaluated the presence of various TLR by staining with antibodies and subsequent quantification by flow cytometry , the presence of TLR2 , TLR3 , TLR4 and TLR9 was observed . To assess changes in the immunosuppressive , activated T lymphocytes and labeled intracellularly potential were co-cultured with MSC stimulated with LPS , poly IC and oligonucleotides with CpG motifs : DSP30 , CpG - A and CpG - B , and their proliferation measured by flow cytometry. As a result , it was observed that stimulation with LPS and DSP30 led to loss of stress and suppressing ability , respectively, while simultaneous stimulation with LPS and DSP30 resulted in maintenance. Such modulations in immunosuppression were corroborated when assessing modulations in gene expression , given that the stimulus induced by LPS and DSP30 in increased expression of TGFb and IL1 , respectively. Then , the effect of the same experimental conditions inducing proliferation of MTC to be measured changes in the amount of cells in a High Content Screening equipment (HCS ) was measured . As a result , it was observed that only the DSP30 treatment was able to significantly increase the amount of cells, phenomenon to be measured supported DNA synthesis through the use of a commercial product followed by analysis by flow cytometry . In order to evaluate possible modulations in NF-kB pathway , CTM stimulated with LPS or DSP30 were subjected to chromatin immunoprecipitation assay , using antibodies specific to subunits RelA and RelB , and the immunoprecipitated DNA subjected to quantitative PCR with primers specific to the promoter regions of VCAM-1 gene. As a result , it was observed that stimulation with LPS increased the activity of RelA , while effects were not observed after stimulation with DSP30 . However , simultaneous stimulation with both ligands led to increased activity of RelA and RelB . When these conditions are evaluated in an assay in HCS immunofluorescence analysis , we observed higher levels of RelB protein in the cytoplasm of cells treated with DSP30 , suggesting an increase in their formation. Although the molecular mechanisms underlying the observed results still require further elucidation , our work indicates that stimulation of MSC with DSP30 can bring benefits in terms of enhancing immunosuppression and cell proliferation , and prevent loss of immunosuppression resulting from the interaction with LPS . These results can serve as guidelines for the improvement of immunotherapies using CTM bone marrow , especially in cases of patients with infections caused by pathogens.

Nos últimos anos, notou-se aumento da incidência de carcinoma espinocelular de orofaringe (CECOF) associado ao HPV. Sabe-se que CECOF associado ao HPV apresenta melhor prognóstico do que CECOF não infectado por HPV. Inúmeros estudos em carcinoma cervical demonstram alterações de TLRs, isto provavelmente devido às associações das oncoproteínas E6 e E7 com estes receptores. Em humanos, existem 10 TLRs identificados, os quais colaboram na resposta imune contra bactérias, fungos e vírus, bem como colaboram na promoção ou regressão do tumor. Esta influência do TLR na carcinogênese tem sido alvo de inúmeros estudos devido à ligação entre inflamação e o câncer. O presente trabalho teve como objetivo verificar diferenças na expressão e função de receptores Toll-like em carcinoma espinocelular de orofaringe (CECOF). Para tal, foram utilizados trinta e sete espécimes diagnosticados como CECOF e a expressão imuno-histoquímica das proteínas p16 e TLR4 analisadas. Duas linhagens de CECOF HPV16 + e duas CECOF HPV-. foram utilizadas para análise da expressão de TLR1-10, IL-6 e IL-8, por qPCR. A detecção dos principais TLRs (TLR1, TLR2, TLR6 e TLR4) foi feita por citometria de fluxo. Para ativação da via de sinalização de TLR2, e posterior análise da expressão de IL6 e IL8, as células foram estimuladas com peptidoglicano. Para verificar a expressão e função de TLR4, as células foram estimuladas com LPS e LPS UP para posterior análise de IL-6 e IL-8, por ELISA. Os resultados demonstraram diferenças na expressão gênica de TLR1 e TLR6 entre as linhagens HPV- e o grupo HPV+ e diferenças na expressão proteica de TLR9. TLR2 apresentou aumento da expressão proteica em todas as linhagens e demonstra desencadeamento da resposta imune, com secreção de IL6 e IL8 nas linhagens HPV- (SCC72 e SCC89) e em uma das linhagens HPV+ (SCC2). Interessantemente, TLR4 não apresentou diferenças significativas na expressão gênica e proteica. Entretanto, as linhagens HPV+ não demonstraram resposta pró-inflamatória mesmo quando estimuladas com LPS e LPS ultra puro, agonista específico de TLR4. Assim, este trabalho contribui para estabelecer o perfil da expressão dos receptores Toll-like em linhagens celulares de CECOF HPV- e HPV+, e aponta para alterações ocorridas na via de sinalização mediada por TLR4. Além disso, nossos resultados abrem portas para futuros estudos na avaliação de alterações causadas no sistema imune inato pelo HPV, em carcinomas espinocelulares de orofaringe. / The incidence of HPV- associated oropharynx squamous cell carcinoma (OPSCC) has increased in recent years. HPV- associated OPSCC has a better prognosis than OPSCC not infected with HPV. In cervical carcinoma, HPV oncoproteins E6 and E7 influence the expression of Toll-like receptors (TLR). To date, 10 TLRs have been identified in humans and many are important for the detection of bacteria, fungi and viruses, as well as regression and tumor promotion. This influence of TLR in carcinogenesis has been the subject of numerous studies, due to the connection between inflammation and cancer. This study aimed to determine differences in the expression and function of Toll-like receptor in OPSCC. Thirty-seven tumours were selected and immunohistochemistry for p16 and TLR4 was performed. Two HPV16-associated OPSCC and two OPSCC not associated to HPVcell lines were used. qPCR was performed to analyze the expression of TLR1-10, IL-6 and IL-8. The detection of the main TLRs (TLR1, TLR2, TLR6 and TLR4) was performed by flow cytometry. For activation of the TLR2-signaling pathway and subsequent analysis of IL6 and IL8 expression, cells were stimulated with peptidoglycan. To verify the expression and function TLR4 cells were stimulated with LPS and LPS UP and subsequent analysis of IL-6 and IL-8 by ELISA. The results showed differences in the expression of TLR1 and TLR6 between the HPV- group and the HPV+ group and differences in protein expression of TLR9. TLR2 has increased protein expression in all cell lines and demonstrates the trigger of the immune response, with the secretion of IL6 and IL8 in HPV- cell lines (SCC72 and SCC89) and one HPV+ cell line (SCC2). Interestingly, TLR4 showed no significant differences in gene and protein expression. However, HPV+ cell lines showed no pro-inflammatory response even when stimulated with LPS and LPS UP, a specific agonist of TLR4. This work helps to establish the profile of the expression of Toll-like receptors in OPSCC (SCC72 and SCC89) and HPV- associated OPSCC (SCC2 and SCC90), in vitro, and points to changes in the signaling pathway mediated by TLR4. In addition, our results open new avenues for future studies to assess changes in the innate immune system caused by HPV in oropharynx carcinomas.

O melanoma é o mais agressivo tumor da pele, cuja resistência aos tratamentos quimioterápicos tem promovido a crescente utilização de imunoquimioterapia, como é o caso da utilização de agonistas dos receptores Toll-Like (TLRs). Nesse contexto, os compostos abreviados por P-MAPA e seu sintético estrutural MRB-CFI-1 com reconhecidas propriedades antitumorais e imunológicas, são fortes candidatos na terapia e prevenção desse tipo de câncer. Esse estudo visa determinar o potencial anticâncer do P-MAPA e de MRB-CFI-1 contra o melanoma murino em consequência ao padrão de resposta microambiental semelhante ao de morte imunogênica, em regimes de tratamento terapêutico ou vacinal, na vigência de quimioterapia com cisplatina e/ou em associação com antígenos de células tumorais totais. Após avaliação In vivo do crescimento de tumores B16F10 implantados em modelos murinos selvagem e nocaute para o gene Myd88, na vigência ou não do tratamento com cisplatina e/ou P-MAPA, nossos resultados mostraram que o P-MAPA apresentou atividade pró-tumoral e antagonizou a ação da cisplatina em inibir o crescimento dos tumores, de forma dependente de Myd88. Além disso, através de análises qualitativa e quantitativa pelo software ImageJ em fotomicrografias de secções tumorais coradas histologicamente, observamos que o P-MAPA promoveu mudanças microambientais nos tumores que podem impactar negativamente em seu desempenho. Como monoterapia em esquema de vacinação com lisado tumoral total em combinação com quimioterapia, o P-MAPA em dose baixa falhou em suprimir o crescimento de tumores B16F10, mas o seu sintético MRB-CFI-1 foi capaz de prevenir o crescimento desse tipo de melanoma num regime de vacinação profilática. Apesar do sucesso terapêutico desse imunomodulador em diversos modelos de câncer e de doenças infecciosas, o P-MAPA não foi eficaz em produz respostas microambientais contra o melanoma murino, dados esses que limitam a aplicabilidade clínica do composto. De outro modo, o composto fosfato inorgânico MRB-CFI-1 foi protetivo em retardar o aparecimento desse tipo de doença. Assim, o presente estudo foi importante por ampliar o entendimento funcional do P-MAPA numa abordagem imunoquimioterápica em modelos biológicos de tumores de melanoma, e representa uma importante mudança na utilização de constituintes individuais similares ao P-MAPA que sejam mais eficazes, de fácil obtenção, e de produção controlada e garantida / Melanoma is the most aggressive skin cancer, whose resistance to chemotherapeutic treatments has promoted the increasing use of immunochemotherapy, as is the case for the use of Toll-Like receptor agonists (TLRs). In this context, the compounds abbreviated by P-MAPA and its structural synthetic MRB-CFI-1 with recognized antitumor and immunological properties are strong candidates in the therapy and prevention of this type of cancer. This study aims to determine the anti-cancer potential of P-MAPA and MRB-CFI-1 against murine melanoma as a consequence of the microenvironmental response pattern similar to that of immunogenic death in therapeutic or vaccine treatment regimens when using chemotherapy with cisplatin alone or in combination with whole tumor cell antigens. After In vivo evaluation of the growth of B16F10 tumors implanted in wild-type and Myd88 gene knockout mice, under treatment or not with cisplatin and / or P-MAPA, our results showed that P-MAPA showed pro-tumor activity and antagonized the action of cisplatin in inhibiting the growth of tumors in a Myd88-dependent manner. In addition, using qualitative and quantitative analysis by ImageJ software in histological images of tumor sections, we observed that P-MAPA promoted microenvironmental changes in tumors that may negatively impact its performance. As monotherapy in vaccination schedule with total tumor lysate in combination with chemotherapy, low dose P-MAPA failed to suppress the growth of B16F10 tumors, but its synthetic MRB-CFI-1 was able to prevent the growth of this type of melanoma in prophylactic vaccination regimen. Despite the therapeutic success of this immunomodulator in various cancer models and infectious diseases, P-MAPA has not been effective in producing microenvironmental responses against murine melanoma, data that limit the clinical applicability of the compound. Otherwise, the inorganic phosphate compound MRB-CFI-1 was protective in delaying the onset of this type of disease. Thus, the present study was important because it broadened the functional understanding of P-MAPA in an immuno-chemotherapeutic approach in biological models of melanoma tumors and represents an important change in the use of individual constituents similar to P-MAPA that are more efficient, easily obtainable, and controlled and guaranteed production

Os mecanismos imunológicos que governam a interação entre o fungo Paracoccidioides brasiliensis e o hospedeiro têm sido pouco estudados. Tanto os componentes do fungo como os receptores dos fagócitos envolvidos nesta interação são pouco conhecidos. Baseados nestes fatos, nosso trabalho teve por objetivo caracterizar in vitro e in vivo o envolvimento do receptor Toll Like-2 (TLR-2) e da proteína adaptadora MyD88 (myeloid differentiation primary response gene 88) na infecção de camundongos pelo P. brasiliensis. O TLR-2 é um receptor da imunidade inata envolvido no reconhecimento de PAMPs (padrões moleculares associados aos patógenos), enquanto que MyD88 é uma molécula envolvida na sinalização celular induzida por muitos TLRs e que culmina com a ativação de vários fatores de transcrição, entre eles o NFB, envolvidos na ativação de genes ligados à resposta inflamatória. Para tanto, utilizamos camundongos C57Bl/6 deficientes e normais para TLR-2 e para MyD88. Demonstramos que, comparado ao grupo controle, animais TLR2-/- apresentavam uma infecção pulmonar menos grave associada com menor síntese de óxido nítrico (NO). Resultados equivalentes foram obtidos com macrófagos peritoneais e alveolares infectados in vitro. Inesperadamente, apesar das diferenças na carga fúngica, ambas as linhagens apresentavam tempo médio de sobrevida semelhante e lesões pulmonares de gravidade equivalente. Os estudos com leucócitos infiltrantes de pulmão revelaram um aumento de leucócitos polimorfonucleares neutrófilos (PMNs) nos animais TLR-2-/- associado com um menor número de linfócitos TCD4+ e TCD8+ ativados. Animais TLR-2-/- deficientes apresentaram uma discreta diferença quanto à síntese de citocinas pulmonares dos tipos Th1 e Th2, porém estes animais apresentaram maiores níveis de KC, uma quimiocina CXC envolvida na quimiotaxia de neutrófilos, assim com maiores níveis de citocinas Th17 (IL-6, IL-17, IL-23 e TGF-). Além disso, a resposta imune Th17 desenvolvida por animais TLR-2-/- esteve associada com menor expansão de células T regulatórias CD4+CD25+FoxP3+. Assim, o TLR-2 controla a imunidade inata e adaptativa frente ao P. brasiliensis e regula negativamente a resposta imune Th17 e a patologia pulmonar. Em relação aos estudos com animais deficientes para a proteína adaptadora MyD88 na paracoccidioimicose verificamos que sua ausência resultou numa produção deficiente in vitro e in vivo de NO, além de uma produção deficiente in vivo de citocinas do tipo Th1, Th2 e Th17. Animais MyD88-deficientes infectados desenvolveram uma resposta imune prejudicada, evidenciada pelo menor número de macrófagos ativados, assim como uma imunidade adaptativa menos eficiente, evidenciada pelo menor número de células T CD4 ativadas que afluíram aos pulmões. Este quadro culminou com uma carga fúngica maior nos pulmões dos animais MyD88- deficientes, como também permitiu uma exuberante disseminação do fungo para outros órgãos, como fígado e baço. Os pulmões e o fígado apresentaram graves lesões com a presença de granulomas coalescentes e ricos agregados fúngicos. Assim, camundongos MyD88-deficientes não foram capazes de controlar a doença e morreram em um tempo mais curto que os animais MyD88-competentes, como evidenciado em experimentos de sobrevida. Assim, nossos achados demonstram que a sinalização intracelular mediada pela proteína MyD88 é importante para a ativação dos mecanismos fungicidas, assim como para a ativação das respostas imunes inata e adaptativa contra o P. brasiliensis. Em conjunto, nosso trabalho demonstra que tanto o TLR-2 quanto a molécula adaptadora MyD88 desempenham um papel relevante no controle da infecção, assim como na indução da resposta imune contra este patógeno fúngico primário. / The immunological mechanisms that govern the interaction between hosts and the dimorphic fungus Paracoccidioides brasiliensis have been scarcely studied. Both, fungal and phagocyte receptors involved in this interaction are poorly understood. Based on these facts, the aim of our study was to characterize in vitro and in vivo the role played by Toll Like Receptor-2 (TLR-2) and the adaptor protein MyD88 (myeloid differentiation primary response gene 88) in murine pulmonary paracoccidioidomycosis. The TLR-2 is a receptor of innate immunity involved in the recognition of PAMPs (pathogen associated molecular patterns), whereas MyD88 is a molecule involved in cell signaling induced by many TLRs . TLR-mediated activation results in the production of several nuclear transcription factors, including NFB, which activate important genes of the inflammatory response. Wild-type (WT) besides TLR- 2- and MyD88-deficient C57Bl/6 mice were used in our investigation. We showed that, compared to control animals, TLR2-/- mice developed a less severe pulmonary infection associated with reduced synthesis of nitric oxide (NO). Equivalent results were obtained with in vitro infected peritoneal and alveolar macrophages. Unexpectedly, despite the differences in fungal loads, TLR-2-/- and WT mice showed equivalent survival times and pulmonary lesions. Studies with lung infiltrating leukocytes revealed an increase of polymorphonuclear neutrophil leukocytes (PMNs) in TLR-2-/- mice associated with a low number of activated T CD4 and T CD8+ lymphocytes. Compared with WT mice, the TLR-2-deficient mice showed slight differences in the production of pulmonary Th1 and Th2 cytokines, but presented higher levels of KC, a CXC chemokine involved in neutrophil chemotaxis, besides increased levels of Th17 cytokines ( IL-6, IL-17, IL-23 and TGF-). Furthermore, the prevalent Th17 immune response developed by TLR-2-/- mice was associated with lower expansion of regulatory T cells CD4+CD25+FoxP3+. Thus, TLR-2 controls the innate and adaptive immunity against the P. brasiliensis infection and negatively regulates Th17 immune response and pulmonary pathology. Studies with MyD88-deficient mice showed an impaired production of NO in vivo and in vitro, and a deficient in vivo production of Th1, Th2 and Th17 cytokines. In addition, infected MyD88-deficient mice developed an impaired immune response, evidenced by poorly activated macrophages, as well as by an inefficient adaptive immunity mediated by a diminished influx of activated CD4+ T cells to the lungs. These events led to increased fungal loads in the lungs of MyD88-deficient mice and allowed a marked dissemination of the fungus to other organs such as liver and spleen, which presented severe lesions composed by coalescent granulomas containing high numbers of fungal cells. As consequence, MyD88-deficient mice were unable to control fungal growth and presented a decreased survival time. Our findings demonstrate that MyD88 signaling is important to the activation of fungicidal mechanisms and to the induction of the innate and adaptive immunity against P. brasiliensis. Altogether, our work shows that both TLR-2 and the adapter molecule MyD88, play an important role in controlling of P. brasiliensis infection, as well as in the induction of immune responses against this primary fungal pathogen.